• Contact us
  • Advertising Policy
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
  • Terms of Use
Wednesday, July 16, 2025
26 °c
Agartala
enewstime
  • Home
  • News
    • Northeast
    • National
    • International
    • Tripura News
  • Sports
    Kokrajhar rolls out red carpet for 134th Indian Oil Durand Cup trophies

    Kokrajhar rolls out red carpet for 134th Indian Oil Durand Cup trophies

    India women will be testing all departments before ODI WC: Anjum Chopra ahead of England series

    India women will be testing all departments before ODI WC: Anjum Chopra ahead of England series

    Jadeja should've played more strokes, people will forget this 61 not out: Surinder Khanna

    Jadeja should've played more strokes, people will forget this 61 not out: Surinder Khanna

    USMNT to meet Ecuador, Australia in October friendlies

    USMNT to meet Ecuador, Australia in October friendlies

    FIFA Prez Infantino has done a great job, says Trump after Club WC final

    FIFA Prez Infantino has done a great job, says Trump after Club WC final

    Aditi finishes T-28 as Australian Grace Kim wins Evian Championship

    Aditi finishes T-28 as Australian Grace Kim wins Evian Championship

    Cricket icons set to return to spotlight in World Championship of Legends

    Cricket icons set to return to spotlight in World Championship of Legends

    I have no words for players, they all deserve this: Maresca after Chelsea's Club WC triumph

    I have no words for players, they all deserve this: Maresca after Chelsea's Club WC triumph

    Golf: Aditi Ashok lies seventh at halfway mark in Evian Championship

    Golf: Aditi Ashok lies seventh at halfway mark in Evian Championship

  • Business
  • Entertainment
  • Health
  • Features
  • TendersNew
No Result
View All Result
  • Home
  • News
    • Northeast
    • National
    • International
    • Tripura News
  • Sports
    Kokrajhar rolls out red carpet for 134th Indian Oil Durand Cup trophies

    Kokrajhar rolls out red carpet for 134th Indian Oil Durand Cup trophies

    India women will be testing all departments before ODI WC: Anjum Chopra ahead of England series

    India women will be testing all departments before ODI WC: Anjum Chopra ahead of England series

    Jadeja should've played more strokes, people will forget this 61 not out: Surinder Khanna

    Jadeja should've played more strokes, people will forget this 61 not out: Surinder Khanna

    USMNT to meet Ecuador, Australia in October friendlies

    USMNT to meet Ecuador, Australia in October friendlies

    FIFA Prez Infantino has done a great job, says Trump after Club WC final

    FIFA Prez Infantino has done a great job, says Trump after Club WC final

    Aditi finishes T-28 as Australian Grace Kim wins Evian Championship

    Aditi finishes T-28 as Australian Grace Kim wins Evian Championship

    Cricket icons set to return to spotlight in World Championship of Legends

    Cricket icons set to return to spotlight in World Championship of Legends

    I have no words for players, they all deserve this: Maresca after Chelsea's Club WC triumph

    I have no words for players, they all deserve this: Maresca after Chelsea's Club WC triumph

    Golf: Aditi Ashok lies seventh at halfway mark in Evian Championship

    Golf: Aditi Ashok lies seventh at halfway mark in Evian Championship

  • Business
  • Entertainment
  • Health
  • Features
  • TendersNew
No Result
View All Result
enewstime
  • Home
  • News
  • Sports
  • Business
  • Entertainment
  • Health
  • Features
  • Tenders
Home Health

From lab to trials: Delhi University’s stride towards a Parkinson’s cure

ENEWSTIME Desk by ENEWSTIME Desk
November 12, 2023
in Health
30
VIEWS
Share on FacebookShare on Twitter

Parkinson’s disease (PD) is a serious illness, affecting more than 10 million people worldwide. Tremors, excessive shaking of the entire body or limbs, stiffness, slowed walking, and difficulty in movement are its primary manifestations.

The disease also becomes a cause for severe depression among patients. Currently, there is no cure for PD available in the market. 

However, India has now discovered a potential treatment for this incurable disease, and its clinical trials have begun in the US.

Delhi University has identified a specific protein that could lead to the treatment of this disease. 

The clinical trials for the molecule (ATM 399A) developed by Professor Diwan S. Rawat of Delhi University and Professor Kim at the McLean Hospital in the US have commenced.

PD is a neuro-degenerative disorder, with common symptoms such as tremors, stiffness, slow movements, and difficulty in walking, leading to noticeable behavioural issues like depression and anxiety.

The primary cause of this disease is the death of neurons in the substantia nigra, located in the middle part of the brain. This results in a deficiency of dopamine and some proteins are essential for the existence of dopamine neurons.

In the pursuit of finding a cure for this serious ailment, researchers under the leadership of Rawat have initiated clinical trials for a synthesised molecule (ATH-399A). 

The research collaboration involves assistance from McLean Hospital in Boston, the US.

Rawat said: “It has been a long journey. Creating something like this requires a tremendous amount of energy. Sometimes you lose patience because one has to overcome numerous obstacles, from obtaining research funding to filing patents and signing technology transfer agreements. However, we remained focused, and now our molecule has reached a level where we can hope for some benefits to humanity.”

In 2021, Delhi University and McLean Hospital reached an agreement, with NurrOn Pharmaceuticals joining as a partner to develop this molecule. 

Later, HanAll BioPharma and Daewoong Pharmaceutical collaborated with NurrOn Pharmaceuticals, initiating the administration of the first dose to a human participant in Phase 1 of clinical trials.

The Phase 1 study involves healthy participants aged 18 to 80, receiving oral doses of ATH-399A to assess safety, tolerability, pharmacokinetics, and food effects.

The study comprises both single ascending dose (SAD) and multiple ascending dose (MAD) groups. 

Initial results for Phase 1 clinical trials of ATH-399A are expected in the second half of 2024. 

The Michael J. Fox Foundation (MJFF) for Parkinson’s Research supports Phase 1 clinical trials of ATH-399A.

According to researchers, animal model studies have revealed that this molecule activates the crucial Nur1 enzyme, preventing the death of dopamine neurons and inhibiting the aggregation of synuclein protein. These findings were recently published in Nature Communications.

Rawat said: “Recently, Neurone Pharmaceuticals gave a research grant of Rs 1 crore. However, as I am currently on probation, DU rules do not permit us to enroll PhD students.”

He told IANS that the collaborative work with the US began in 2012. 

Kim from McLean Hospital contacted Rawat for potential collaboration on developing a molecule for Parkinson’s disease treatment. 

Since then, both teams have worked diligently, and Delhi University researchers have tested over 600 newly-synthesised compounds.

*Except for the heading, this story has not been edited by The enewstime.in and has been published from an Agency feed.

Related Posts

‘Love hormone’ can fix mood changes in women with disturbed sleep
Health

‘Love hormone’ can fix mood changes in women with disturbed sleep

July 15, 2025
Dr Jitendra Singh bats for holistic healthcare, calls for restoring doctor-patient trust
Health

Dr Jitendra Singh bats for holistic healthcare, calls for restoring doctor-patient trust

July 15, 2025
WHO recommends twice-a-year lenacapavir jab to boost global HIV prevention
Health

WHO recommends twice-a-year lenacapavir jab to boost global HIV prevention

July 15, 2025
DRDO, AIIMS Telangana unveil indigenous low-cost prosthetic foot
Health

DRDO, AIIMS Telangana unveil indigenous low-cost prosthetic foot

July 15, 2025
‘Youth Spiritual Summit’ in Varanasi to kick off special drive against drug addiction: Mansukh Mandaviya
Health

‘Youth Spiritual Summit’ in Varanasi to kick off special drive against drug addiction: Mansukh Mandaviya

July 15, 2025
TN schools to display ‘oil, sugar, salt’ boards to raise safety awareness
Health

TN schools to display ‘oil, sugar, salt’ boards to raise safety awareness

July 15, 2025
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
D-2050 D-2050 D-2050
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT

About us

Enewstime.in is run by an individual – a Journalist by profession of Tripura with the active help of several journos including senior journalists of the State. On top of that, Enewstime.in being a subscriber of IANS news agency, we have plenty of multi-choice topics to offer to our esteemed readers. Enewstime.in is a venture reach global audience from a tiny State Tripura.

Latest News

‘Love hormone’ can fix mood changes in women with disturbed sleep

Dr Jitendra Singh bats for holistic healthcare, calls for restoring doctor-patient trust

Smriti Irani taking a sabbatical from politics? 'Kyunki Saas Bhi Kabhi Bahu Thi' actress reacts

Himachal CM meets Finance Commission head, seeks assistance

Kokrajhar rolls out red carpet for 134th Indian Oil Durand Cup trophies

WHO recommends twice-a-year lenacapavir jab to boost global HIV prevention

Contact us

19, Old Thana Road. Banamalipur. PO. Agartala. Pin code 799001. Tripura (West), India.

Email: enewstime2017@gmail.com

Wa: 8794548041

  • Contact us
  • Advertising Policy
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
  • Terms of Use

© 2025 Designed & Developed with ❤️ by Provibe Media LLP

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • News
    • Northeast
    • National
    • International
    • Tripura News
  • Sports
  • Business
  • Entertainment
  • Health
  • Features
  • Tenders

© 2025 Designed & Developed with ❤️ by Provibe Media LLP